869 related articles for article (PubMed ID: 33010111)
1. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
[TBL] [Abstract][Full Text] [Related]
3. Cell population data: Could a routine hematology analyzer aid in the differential diagnosis of COVID-19?
Lapić I; Brenčić T; Rogić D; Lukić M; Lukić I; Kovačić M; Honović L; Šerić V
Int J Lab Hematol; 2021 Apr; 43(2):e64-e67. PubMed ID: 33079479
[No Abstract] [Full Text] [Related]
4. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
5. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
6. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
[TBL] [Abstract][Full Text] [Related]
7. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
8. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
9. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
[TBL] [Abstract][Full Text] [Related]
15. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
[TBL] [Abstract][Full Text] [Related]
16. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
[TBL] [Abstract][Full Text] [Related]
17. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
18. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
[TBL] [Abstract][Full Text] [Related]
19. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
